2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and …

RA Byrne, S Fremes, D Capodanno… - European Journal of …, 2023 - academic.oup.com
Task Force structure and summary of clinical evidence of 2022 ESC/EACTS review of the
2018 guideline recommendations on the revascularization of left main coronary artery …

[HTML][HTML] Percutaneous coronary intervention versus coronary artery bypass graft for left main coronary artery disease: a meta-analysis

M Gallo, D Blitzer, PL Laforgia, IP Doulamis… - The Journal of thoracic …, 2022 - Elsevier
Background The optimal revascularization strategy for patients with left main coronary artery
disease is still controversial. This is systematic review and meta-analysis aims to evaluate …

Long-term outcomes of coronary artery bypass grafting versus stent-PCI for unprotected left main disease: a meta-analysis

S De Rosa, A Polimeni, J Sabatino, C Indolfi - BMC Cardiovascular …, 2017 - Springer
Background Coronary artery bypass graft (CABG) surgery has traditionally represented the
standard of care for left main coronary artery (LMCA) disease. However, percutaneous …

Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta …

MS Sabatine, BA Bergmark, SA Murphy, PT O'Gara… - The Lancet, 2021 - thelancet.com
Background The optimal revascularisation strategy for patients with left main coronary artery
disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated …

Percutaneous coronary intervention of left main disease: pre-and post-excel (evaluation of xience everolimus eluting stent versus coronary artery bypass surgery for …

DW Park, SJ Park - Circulation: Cardiovascular Interventions, 2017 - Am Heart Assoc
For nearly half a century, coronary artery bypass grafting has been the standard treatment
for patients with obstructive left main coronary artery (LMCA) disease. However, there has …

Management of left main disease: an update

J Fajadet, D Capodanno, GW Stone - European Heart Journal, 2019 - academic.oup.com
A severe narrowing of the left main coronary artery (LMCA), usually due to atherosclerosis,
jeopardizes a large area of myocardium and increases the risk of major adverse cardiac …

Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials

Y Ahmad, JP Howard, AD Arnold… - European Heart …, 2020 - academic.oup.com
Aims The optimal method of revascularization for patients with left main coronary artery
disease (LMCAD) is controversial. Coronary artery bypass graft surgery (CABG) has …

Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between …

MC Morice, PW Serruys, AP Kappetein, TE Feldman… - Circulation, 2014 - Am Heart Assoc
Background—Current guidelines recommend coronary artery bypass graft surgery (CABG)
when treating significant de novo left main coronary artery (LM) stenosis; however …

Bayesian interpretation of the EXCEL trial and other randomized clinical trials of left main coronary artery revascularization

JM Brophy - JAMA Internal Medicine, 2020 - jamanetwork.com
Importance Patients with left main coronary artery disease have improved outcomes with
coronary revascularization compared with medical therapy, but the choice of optimal …

Percutaneous coronary intervention for left main coronary artery disease: present status and future perspectives

S Park, SJ Park, DW Park - JACC: Asia, 2022 - jacc.org
For several decades, coronary artery bypass grafting has been regarded as the standard
choice of revascularization for significant left main coronary artery (LMCA) disease …